Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
JPMorgan Chase & Co
(NY:
JPM
)
322.21
-0.19 (-0.06%)
Streaming Delayed Price
Updated: 3:34 PM EST, Feb 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about JPMorgan Chase & Co
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
43
44
Next >
JPMorganChase Announcement Concerning Preferred Stock
January 27, 2025
From
JPMorgan Chase & Co.
Via
Business Wire
Red Badger hires Houses of Parliament CIO to lead new Public Sector practice
January 22, 2025
Via
Get News
Topics
Artificial Intelligence
STAU Project: Bridging Traditional Gold and Digital Assets Through Web3 Innovation
January 20, 2025
Via
Binary News Network
Topics
Bonds
ETFs
Government
Global Recognition Awards Appoints Mahendravarman Sampathu as Judge
January 17, 2025
Via
Press Release Distribution Service
Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP
January 02, 2025
NRx Pharmaceuticals, Inc.: Stock Symbol: NRXP IS Aiming to be the First FDA-Approved Medication to Treat Suicidal DepressionMIAMI - Jan. 2, 2025 - PRLog -- Developing NRX-101, an FDA-Designated...
Via
PRLog
Topics
Intellectual Property
New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
December 30, 2024
$NRXP: Completion of NDA Filing Expected in First Quarter of 2025MIAMI - Dec. 30, 2024 - PRLog -- Developing NRX-101, an FDA-Designated Investigational Breakthrough Therapy for Suicidal...
Via
PRLog
22 Entrepreneurs Graduate from Arizona’s Largest Supplier Diversity Program, Impact AZ, Driving Economic Growth and Innovation
January 16, 2025
PHOENIX, Ariz., Jan. 16, 2025 (SEND2PRESS NEWSWIRE) -- Twenty-two entrepreneurs graduated from the Impact AZ 2025 Supplier Diversity Accelerator on Tuesday, January 14, during a ceremony held at the...
Via
Send2Press
Topics
Supply Chain
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 16, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 16, 2025
Focusing on Neuroscience, Oncology, and Ophthalmology Pipelines
Via
TheNewswire.com
JPMorganChase Declares Preferred Stock Dividends
January 15, 2025
From
JPMorgan Chase & Co.
Via
Business Wire
InvestorNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Positioning with Dynamic Approach to Sports Ownership
January 15, 2025
Via
Investor Brand Network
Topics
Regulatory Compliance
JPMorganChase Reports Fourth-Quarter and Full-Year 2024 Financial Results
January 15, 2025
From
JPMorgan Chase & Co.
Via
Business Wire
Ammunition Appoints Kate Grafton as VP of Client Engagement
January 14, 2025
Atlanta, Georgia--(Newsfile Corp. - January 14, 2025) - Ammunition, an Atlanta-based full-funnel advertising agency, has appointed Kate Grafton as Vice...
Via
Newsfile
JPMorganChase Announces New Responsibilities for Senior Leaders
January 14, 2025
From
JPMorgan Chase & Co.
Via
Business Wire
Stocks to Watch in 2025: PHIO, LPTH, KAVL, Promising Innovations, Growth Opportunities, Etc. … more inside
January 13, 2025
Via
AB Newswire
Topics
Regulatory Compliance
Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
January 13, 2025
The Company will present at the Annual J.P. Morgan Healthcare Conference, providing business updates on its sarcoma franchise and other...
Via
Newsfile
InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) to Present Broad-Spectrum Antiviral Innovations at Biotech Showcase 2025
January 13, 2025
Via
Investor Brand Network
Topics
Intellectual Property
BioUtah to Attend the J.P. Morgan 43rd Annual Healthcare Conference
January 09, 2025
Salt Lake City, Utah--(Newsfile Corp. - January 9, 2025) - BioUtah, the trade association,...
Via
Newsfile
JPMorganChase, Axios, and U.S. Conference of Mayors Partner to Highlight and Scale Solutions in Local Communities
January 09, 2025
From
JPMorgan Chase & Co.
Via
Business Wire
SUNRATE Expands Beyond Global Payments in 2025 by Introducing New Treasury Solutions
January 08, 2025
SINGAPORE - Media OutReach Newswire - 9 January 2025 - SUNRATE, the global payment and treasury management platform, kickstarts the new year by introducing...
Via
MediaOutReach
JPMorganChase Survey: Businesses Ring in the New Year with Renewed Optimism
January 07, 2025
From
JPMorgan Chase & Co.
Via
Business Wire
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
January 06, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
January 06, 2025
ATLANTA, GA - January 6, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced...
Via
TheNewswire.com
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Engage Investors and Partners at Key January Conferences
January 06, 2025
Via
Investor Brand Network
OS Therapies Partners With B2i Digital to Engage With Biotech Investors Online
December 26, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at JP Morgan 2025 Annual Healthcare Conference
December 23, 2024
Via
Investor Brand Network
Topics
Intellectual Property
J.P. Morgan Wealth Management Ranks #1 in J.D. Power Digital Experience Study
December 19, 2024
From
JPMorgan Chase & Co.
Via
Business Wire
JPMorganChase to Host Fourth-Quarter and Full-Year 2024 Earnings Call
December 16, 2024
From
JPMorgan Chase & Co.
Via
Business Wire
Chase Freedom® Celebrates 15 Years of Rotating Cash Back Categories, Kicking Off 2025 With: Norwegian Cruise Lines, Grocery Stores, Fitness Clubs and Self-Care Services
December 16, 2024
From
Chase Freedom
Via
Business Wire
JPMorganChase Declares Preferred Stock Dividends
December 13, 2024
From
JPMorgan Chase & Co.
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
43
44
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today